Cannara Biotech8CB0 
$0.50-2.02%24h
-2.02%24h
Global rank23791
Market cap$45.09M
Change 7d-0.41%
YTD Performance-
SP500 benchmark
P/E6.31
P/S1.14
Revenue$39.72M
Earnings$4.82M
Dividend yield-
Main Sector
Healthcare
Cannara Biotech (8CB0) Net Assets
8CB0 Net Assets in 2024: $79.74M
As of 14 Jan 2025, Cannara Biotech net assets is $79.74M, an increase of 19.49% to 2023. Net assets are calculated as total assets minus total liabilities. This value represents the Cannara Biotech overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
Cannara Biotech Net Assets History from 2019 to 2025
-
Value:-
8CB0 Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $79.74M | 19.49% |
| 2022 | $66.74M | 4.09% |
| 2021 | $64.12M | 67.12% |
| 2020 | $38.36M | -23.16% |
| 2019 | $49.93M | - |
View the Top Net Assets Companies
